Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration
- PMID: 27658420
- DOI: 10.1093/brain/aww230
Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration
Abstract
The abnormal aggregation of a small number of known proteins underlies the most common human neurodegenerative diseases. In tauopathies and synucleinopathies, the normally soluble intracellular proteins tau and α-synuclein become insoluble and filamentous. In recent years, non-cell autonomous mechanisms of aggregate formation have come to the fore, suggesting that nucleation-dependent aggregation may occur in a localized fashion in human tauopathies and synucleinopathies, followed by seed-dependent propagation. There is a long prodromal phase between the formation of protein aggregates and the appearance of the first clinical symptoms, which manifest only after extensive propagation, opening novel therapeutic avenues.
Keywords: Alzheimer’s disease; Parkinson’s disease; alpha-synuclein; prion-like; tau.
© The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Similar articles
-
Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.Curr Neurol Neurosci Rep. 2014 Nov;14(11):495. doi: 10.1007/s11910-014-0495-z. Curr Neurol Neurosci Rep. 2014. PMID: 25218483 Review.
-
The interaction of α-synuclein and Tau: A molecular conspiracy in neurodegeneration?Semin Cell Dev Biol. 2020 Mar;99:55-64. doi: 10.1016/j.semcdb.2018.05.005. Epub 2018 May 10. Semin Cell Dev Biol. 2020. PMID: 29738880 Review.
-
Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein.Acta Neuropathol Commun. 2021 Apr 8;9(1):64. doi: 10.1186/s40478-021-01171-0. Acta Neuropathol Commun. 2021. PMID: 33832546 Free PMC article.
-
Alpha-synuclein and tau: teammates in neurodegeneration?Mol Neurodegener. 2014 Oct 29;9:43. doi: 10.1186/1750-1326-9-43. Mol Neurodegener. 2014. PMID: 25352339 Free PMC article. Review.
-
Cell-to-Cell Transmission of Tau and α-Synuclein.Trends Mol Med. 2020 Oct;26(10):936-952. doi: 10.1016/j.molmed.2020.03.012. Epub 2020 May 1. Trends Mol Med. 2020. PMID: 32371172 Free PMC article. Review.
Cited by
-
The 3D structure of lipidic fibrils of α-synuclein.Nat Commun. 2022 Nov 10;13(1):6810. doi: 10.1038/s41467-022-34552-7. Nat Commun. 2022. PMID: 36357403 Free PMC article.
-
Insight Into Seeded Tau Fibril Growth From Molecular Dynamics Simulation of the Alzheimer's Disease Protofibril Core.Front Mol Biosci. 2021 Mar 19;8:624302. doi: 10.3389/fmolb.2021.624302. eCollection 2021. Front Mol Biosci. 2021. PMID: 33816551 Free PMC article.
-
The Synucleins and the Astrocyte.Biology (Basel). 2023 Jan 19;12(2):155. doi: 10.3390/biology12020155. Biology (Basel). 2023. PMID: 36829434 Free PMC article. Review.
-
iPSC-Derived Striatal Medium Spiny Neurons from Patients with Multiple System Atrophy Show Hypoexcitability and Elevated α-Synuclein Release.Cells. 2023 Jan 4;12(2):223. doi: 10.3390/cells12020223. Cells. 2023. PMID: 36672158 Free PMC article.
-
Differentiating amyloid beta spread in autosomal dominant and sporadic Alzheimer's disease.Brain Commun. 2022 Apr 13;4(3):fcac085. doi: 10.1093/braincomms/fcac085. eCollection 2022. Brain Commun. 2022. PMID: 35602652 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical